Purdue, Ranbaxy Settle IP Fight Over Generic Oxycontin
Ranbaxy Laboratories Ltd. has admitted to infringing three Purdue Pharma LP patents and agreed to waive possible antitrust claims under a deal to resolve litigation over the painkiller Oxycontin, which won...To view the full article, register now.
Already a subscriber? Click here to view full article